| 貨號 | 規格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|
S23221-2mg |
99.9% | ￥1105.00 | 10 | - | - | - |
|
S23221-5mg |
99.9% | ￥1870.00 | >10 | - | - | - |
|
S23221-10mg |
99.9% | ￥3060.00 | >10 | - | - | - |
|
S23221-25mg |
99.9% | ￥5700.00 | >10 | - | - | - |
|
CSF1R-IN-1 is a CSF1R inhibitor with an with an IC50 of 0.5 nM
| 產品描述： | CSF1R-IN-1 is a CSF1R inhibitor with an with an IC50 of 0.5 nM | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | IC50: 0.5 nM (CSF1R);c-Fms | ||||||||||||||||||||
| 體內研究： | CSF1R-IN-1 has favorable pharmacokinetics when dosed orally to mice. It appears suitable for in vivo pharmacology testing in the appropriate preclinical tumor model to demonstrate proof of concept. | ||||||||||||||||||||
| 參考文獻： | 1. Ramachandran SA, et al. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors. Bioorg Med Chem Lett. 2017 May 15;27(10):2153-2160. | ||||||||||||||||||||
| 溶解性： | DMSO : 83.33 mg/mL (173.80 mM; Need ultrasonic) | ||||||||||||||||||||
| 保存條件： | -20℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京